Skip to main content
Clinical Trials/KCT0009203
KCT0009203
Completed
未知

Prognostic Nomogram Considering Pathology and Biologic Parameters for Resected Borderline Resectable and Locally Advanced Pancreatic Cancer (BRPC & LAPC) Following Neoadjuvant Chemotherapy

Asan Medical Center0 sites176 target enrollmentTBD
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Asan Medical Center
Enrollment
176
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 9, 2022
Last Updated
2 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Among patients who was treated in Seoul Asan Medical Center, those with available preoperative CA 19\-9 level and PET result

Exclusion Criteria

  • No Curative resection, No available preoperativel level of CA 19\-9, No available preoperative PET

Outcomes

Primary Outcomes

Not specified

Similar Trials